Endocrinology Information Center
HbA1C, diabetes status, and cognitive decline during a span of 10 years were compared using data from the English Longitudinal Study of Ageing.
The ADA's updates include a modified patient-focused care algorithm as well as improved risk management for CVD.
Weight loss in obese individuals may lead to reduced pain, affect, and somatic symptoms associated with chronic pain.
The utility and effectiveness of wearable fitness devices are discussed in a clinician's opinion piece.
Obesity is a chronic, progressive disease, and continued communication on prevention and treatment is paramount to reversing the status quo.
Applying necessary lifestyle changes as well as incorporating pharmaceutical drugs will improve diabetes in patients compared to drugs alone.
UTIs present clinically as dysuria, with symptoms of frequent and urgent urination secondary to irritation of the urethral and bladder mucosa.
A middle-aged patient with morbid obesesity and COPD complains about having shortness of breath at rest and dyspnea on exertion.
With the holiday season in full swing, clinicians and patients alike face difficulties in staying healthy and happy. Click through ...
Alpha-lipoic acid, 600mg daily, is an effective treatment option for patients with diabetic peripheral neuropathy.
Patients should be encouraged to incorporate daily exercise into their treatment regimen.
When symptoms of thyroid disease are present, clinicians should check thyroid antibodies even if thyroid function is normal.
SGLT2 receptor blockers are only approved for type 2 diabetes.
An older male patient started antidepressants for neuropathy pain but developed hyponatremia as a result.
An obese patient with chronic hepatitis C, diabetes, advanced cirrhosis, and fatty pancreas presents with chronic right-to-middle upper-abdomen pain.